Number of the records: 1
Doxorubicin release is not a prerequisite for the in vitro cytotoxicity of HPMA-based pharmaceuticals: In vitro effect of extra drug-free GlyPheLeuGly sequences
- 1.0313690 - MBÚ 2009 RIV NL eng J - Journal Article
Říhová, Blanka - Strohalm, Jiří - Hovorka, Ondřej - Šubr, Vladimír - Etrych, Tomáš - Chytil, Petr - Pola, Robert - Plocová, Daniela - Bouček, Jan - Ulbrich, Karel
Doxorubicin release is not a prerequisite for the in vitro cytotoxicity of HPMA-based pharmaceuticals: In vitro effect of extra drug-free GlyPheLeuGly sequences.
[UVOLNĚNÍ DOXORUBICINU NENÍ V IN VITRO SYSTÉMU PODMÍNKOU UČINNOSTI POLYMERNÍCH LÉČIV NA BÁZI HPMA:IN VITRO ÚČINNEK VOLNÝCH GlyPheLeuGly SEKVENCÍ, KTERÉ NENESOU LÉČIVO.]
Journal of Controlled Release. Roč. 127, č. 2 (2008), s. 110-120. ISSN 0168-3659. E-ISSN 1873-4995
R&D Projects: GA ČR GA204/05/2255; GA AV ČR KAN200200651
Institutional research plan: CEZ:AV0Z50200510; CEZ:AV0Z40500505
Keywords : hpma * apoptosis * necrosis
Subject RIV: EC - Immunology
Impact factor: 5.690, year: 2008
Permanent Link: http://hdl.handle.net/11104/0164429
Number of the records: 1